在动脉样硬化治疗中,免疫调节策略和向传递系统
Wei Jiang1,2, Huan Tang2, Yan Hu3
1Central Hospital of Dalian University of Technology, Dalian, P. R. China.
Expert opinion on drug delivery
|February 23, 2026
概括
精确纳米药物向动脉样硬化 (AS) 炎症至关重要,因为目前的治疗方法会留下残留风险. 未来的战略重点是特定的免疫路径和先进的纳米传递,以获得更好的结果.
科学领域:
- 心血管研究研究心血管研究
- 免疫学 免疫学 免疫学
- 纳米医学是一种纳米医学.
背景情况:
- 动脉样硬化 (AS) 是一种慢性炎症性疾病.
- 单独的降脂疗法就会留下显著的残留心血管风险.
- 免疫调节干预措施对于管理AS至关重要.
研究的目的:
- 审查动脉样硬化的免疫病理学.
- 探索针对AS的向纳米医学策略.
- 综合1990-2024年关于AS免疫病理学和纳米医学的文献.
主要方法:
- 关于AS免疫病理学的文献综合.
- 针对AS的向纳米医学方法的审查.
- 对免疫调节策略和纳米输送系统的分析.
主要成果:
- 关键的AS机制包括巨细胞极化,T细胞功能障碍,炎细胞激活和NETosis.
- 免疫调节正在转向针对特定途径 (例如,DRP1,ANGPTL3,SET7) 的精确干预.
- 纳米交付系统正在向智能,仿生平台发展,以提高精度.
结论:
- 新兴的边界涉及免疫代谢交叉通话和破坏免疫细胞通信.
- 挑战包括斑块透,纳米载体积累和系统性免疫抑制风险.
- 未来的突破需要双模平台,个性化系统和改进的临床翻译模型.
相关概念视频
Atherosclerosis III: Management
476
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
476
Modified-Release Drug Delivery Systems: Site-Targeted
33
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
33
Site-Targeted Drug Delivery Systems: Polymeric Carriers
39
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
39
Modified-Release Drug Delivery Systems: Classification
47
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
47
Atherosclerosis IV: Nursing Management
497
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
497
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K


